Last reviewed · How we verify

levoverbenone

unknown active ✓ Verified May 2026

levoverbenone is a levoverbenone drug. It is currently in unknown development.

Levoverbenone is thought to work by interacting with cellular mechanisms to produce therapeutic effects.

Levoverbenone is an expectorant, a type of medication that helps to loosen and clear mucus from the lungs. It is the (−)-isomer of verbenone, a naturally occurring compound.

At a glance

Generic namelevoverbenone
Drug classlevoverbenone
Therapeutic areaOther
Phaseunknown

Mechanism of action

Imagine your body's cells have a way of communicating with each other through tiny messengers. Levoverbenone may help regulate these messengers to promote healing or reduce inflammation. This process is complex and not fully understood, but it's thought to be the key to levoverbenone's therapeutic benefits.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about levoverbenone

What is levoverbenone?

levoverbenone is a levoverbenone drug.

How does levoverbenone work?

Levoverbenone is thought to work by interacting with cellular mechanisms to produce therapeutic effects.

What drug class is levoverbenone in?

levoverbenone belongs to the levoverbenone class. See all levoverbenone drugs at /class/levoverbenone.

What development phase is levoverbenone in?

levoverbenone is in unknown.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing